158 related articles for article (PubMed ID: 35804942)
1. Effect of Antibacterial Prophylaxis on Febrile Neutropenic Episodes and Bacterial Bloodstream Infections in Dutch Pediatric Patients with Acute Myeloid Leukemia: A Two-Center Retrospective Study.
Van Weelderen RE; Klein K; Goemans BF; Tissing WJE; Wolfs TFW; Kaspers GJL
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804942
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
3. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
4. Retrospective Observational Assessment of the Impact of Cefepime Prophylaxis in Neutropenic Pediatric Patients With Acute Myelogenous Leukemia.
Almatrafi MA; Dassner AM; Aquino V; Slone T; Sebert M
J Pediatric Infect Dis Soc; 2023 Aug; 12(8):471-476. PubMed ID: 37591306
[TBL] [Abstract][Full Text] [Related]
5. Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
Al Omar S; Anabtawi N; Al Qasem W; Rihani R
J Pediatr Hematol Oncol; 2017 Apr; 39(3):e131-e135. PubMed ID: 28234737
[TBL] [Abstract][Full Text] [Related]
6. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
[TBL] [Abstract][Full Text] [Related]
7. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Yeh TC; Hou JY; Huang TH; Lu CH; Sun FJ; Huang HM; Liu HC
Sci Rep; 2021 Oct; 11(1):21142. PubMed ID: 34707164
[TBL] [Abstract][Full Text] [Related]
9. Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia.
Felsenstein S; Orgel E; Rushing T; Fu C; Hoffman JA
Pediatr Infect Dis J; 2015 Apr; 34(4):e78-84. PubMed ID: 25764103
[TBL] [Abstract][Full Text] [Related]
10. High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy.
El Kebbi O; Prather CS; Elmuti L; Khalifeh M; Alali M
Sci Rep; 2023 Apr; 13(1):5627. PubMed ID: 37024512
[TBL] [Abstract][Full Text] [Related]
11. Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.
Kelsey SM; Weinhardt B; Collins PW; Newland AC
Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):509-14. PubMed ID: 1388120
[TBL] [Abstract][Full Text] [Related]
12. A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
Kelsey SM; Collins PW; Delord C; Weinhard B; Newland AC
Br J Haematol; 1990 Dec; 76 Suppl 2():10-3. PubMed ID: 2149044
[TBL] [Abstract][Full Text] [Related]
13. Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.
Kolonen A; Sinisalo M; Huttunen R; Syrjänen J; Aittoniemi J; Huhtala H; Sankelo M; Rintala H; Räty R; Jantunen E; Nousiainen T; Säily M; Kauppila M; Itälä-Remes M; Ollikainen H; Rauhala A; Koistinen P; Elonen E;
Infect Dis (Lond); 2017; 49(11-12):799-808. PubMed ID: 28683646
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
Pohlen M; Marx J; Mellmann A; Becker K; Mesters RM; Mikesch JH; Schliemann C; Lenz G; Müller-Tidow C; Büchner T; Krug U; Stelljes M; Karch H; Peters G; Gerth HU; Görlich D; Berdel WE
Haematologica; 2016 Oct; 101(10):1208-1215. PubMed ID: 27470601
[TBL] [Abstract][Full Text] [Related]
15. Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center Study.
Urbino I; Frairia C; Busca A; Corcione S; D'Ardia S; Dellacasa CM; Giai V; Secreto C; Freilone R; De Rosa FG; Aydin S; Ciccone G; Rosato R; Cerrano M; Audisio E
Mediterr J Hematol Infect Dis; 2023; 15(1):e2023022. PubMed ID: 36908871
[TBL] [Abstract][Full Text] [Related]
16. Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance.
Choi H; Ahn H; Lee R; Cho SY; Lee DG
Infect Chemother; 2022 Jun; 54(2):340-352. PubMed ID: 35794719
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.
Ghadiany M; Rahimi H; Rezvani H; Mohammad Alizadeh A; Zamani N; Mehdizadeh M; Foratyazdi M
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e11-5. PubMed ID: 24330539
[TBL] [Abstract][Full Text] [Related]
18. [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
López A; Soler JA; Juliá A; Novo A; Bueno J
Med Clin (Barc); 1994 Jan; 102(3):81-5. PubMed ID: 8133717
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization.
Zavrelova A; Paterova P; Gabalec F; Zak P; Radocha J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):161-165. PubMed ID: 30198521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
